Geneva, Switzerland

Christian Borel

This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Borel. Retrieved from https://idiyas.com/inventor/christian-borel-tas2uibg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Christian Borel

Introduction

Christian Borel is a notable inventor based in Geneva, Switzerland. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on acyl derivatives of oxazolorifamycins. Her research has the potential to impact the development of new pharmaceutical products.

Latest Patents

Christian Borel holds a patent for "Acyl derivatives of oxazolorifamycins." This invention relates to novel acyl derivatives of rifamycins, which can be utilized as active compounds in medicaments. The patent outlines the structural elements and variations that can be employed in the preparation and use of these compounds, highlighting their potential applications in pharmaceutical products.

Career Highlights

Borel is associated with Ciba-Geigy Corporation, a prominent company in the pharmaceutical industry. Her work there has allowed her to focus on innovative solutions that address medical needs through chemical advancements.

Collaborations

Christian Borel has collaborated with esteemed colleagues such as Wilhelm Kump and John E. Francis. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.

Conclusion

Christian Borel's contributions to the field of medicinal chemistry through her patent and collaborations underscore her role as an influential inventor. Her work continues to pave the way for advancements in pharmaceutical innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…